Showing results (91-100 of 208) with videos related to

Sort By:
Pageof 21
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 2, 2025
Enhancing Sexual Health for Cancer SurvivorsLaila S Agrawal, Liz O'Riordan, Caleb Natale, et al.
ANZ Journal of Surgery|March 3, 2005
Necrotizing fasciitis: analysis of 48 cases in South Auckland, New ZealandAlbert Tiu, Richard Martin, Peter Vanniasingham, et al.
European Urology|August 21, 2010
Liver transplantation techniques for the surgical management of renal cell carcinoma with tumor thrombus in the inferior vena cava: step-by-step descriptionGaetano Ciancio, Javier Gonzalez, Samir P Shirodkar, et al.
The Journal of Urology|June 18, 2004
Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancerPaul D Sved, Pablo Gomez, M Manoharan, et al.
European Urology|June 30, 2009
Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experienceGaetano Ciancio, Murugesan Manoharan, Devendar Katkoori, et al.
Indian Journal of Urology : IJU : Journal of the Urological Society of India|March 2, 2013
Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completionAhmed Eldefrawy, Mark S Soloway, Devendar Katkoori, et al.
Urology|February 19, 2008
Trends in Gleason score: concordance between biopsy and prostatectomy over 15 yearsAyyathurai Rajinikanth, Murugesan Manoharan, Cynthia T Soloway, et al.
European Urology|March 27, 2012
Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocolsViacheslav Iremashvili, Lisét Pelaez, Murugesan Manoharan, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 16, 2011
Oncological and functional outcomes following open radical prostatectomy: how patients may achieve the "Trifecta"?Elie Antebi, Ahmed Eldefrawy, Devendar Katkoori, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate diseaseEdna Gordian, Kavitha Ramachandran, Isildinha M Reis, et al.
Pageof 21